Novel iminobenzoxathiolone compound inhibits nuclear factor-kappaB activation targeting inhibitory kappaB kinase beta and down-regulating interleukin-1beta expression in lipopolysaccharide-activated macrophages

scientific article published on 21 May 2008

Novel iminobenzoxathiolone compound inhibits nuclear factor-kappaB activation targeting inhibitory kappaB kinase beta and down-regulating interleukin-1beta expression in lipopolysaccharide-activated macrophages is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BCP.2008.05.013
P698PubMed publication ID18573490

P2093author name stringYoungsoo Kim
Min Hee Kim
Chong-Kil Lee
Sang-Bae Han
Byung Hak Kim
Eun Yong Chung
Heesoon Lee
Eunmiri Roh
Yong Rok Lee
Hwa Young Lee
In Jeong Lee
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectlipopolysaccharideQ421804
P304page(s)373-381
P577publication date2008-05-21
P1433published inBiochemical PharmacologyQ864229
P1476titleNovel iminobenzoxathiolone compound inhibits nuclear factor-kappaB activation targeting inhibitory kappaB kinase beta and down-regulating interleukin-1beta expression in lipopolysaccharide-activated macrophages
P478volume76

Reverse relations

cites work (P2860)
Q35014224Benzoxathiol derivative BOT-4-one suppresses L540 lymphoma cell survival and proliferation via inhibition of JAK3/STAT3 signaling
Q37310621Immunomodulatory and anti-inflammatory effects of chondroitin sulphate
Q33595330The benzoxathiolone LYR-71 down-regulates interferon-gamma-inducible pro-inflammatory genes by uncoupling tyrosine phosphorylation of STAT-1 in macrophages

Search more.